![]() |
Phase II Multicenter Study of Docetaxel and Bevacizumab (Bev) +/- Trastuzumab for MBC
Abstract:
http://www.abstracts2view.com/sabcs1...=SABCS10L_1100 Poster: http://www.abstracts2view.com/sabcs1...hp?nu=P6-12-08 Hopeful |
| All times are GMT -7. The time now is 04:46 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021